2.37
price up icon4.87%   0.11
after-market Dopo l'orario di chiusura: 2.32 -0.05 -2.11%
loading
Precedente Chiudi:
$2.26
Aprire:
$2.25
Volume 24 ore:
60,483
Relative Volume:
0.18
Capitalizzazione di mercato:
$5.99M
Reddito:
-
Utile/perdita netta:
$-7.32M
Rapporto P/E:
-5.4147
EPS:
-0.4377
Flusso di cassa netto:
$-5.99M
1 W Prestazione:
-0.84%
1M Prestazione:
-27.89%
6M Prestazione:
-40.15%
1 anno Prestazione:
-73.22%
Intervallo 1D:
Value
$2.20
$2.37
Intervallo di 1 settimana:
Value
$2.10
$2.59
Portata 52W:
Value
$2.10
$16.80

Mangoceuticals Inc Stock (MGRX) Company Profile

Name
Nome
Mangoceuticals Inc
Name
Telefono
(833) 626-4679
Name
Indirizzo
15110 DALLAS PKWY, SUITE 600, DALLAS
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
MGRX's Discussions on Twitter

Mangoceuticals Inc Borsa (MGRX) Ultime notizie

pulisher
Nov 04, 2024

Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World

Nov 04, 2024
pulisher
Nov 03, 2024

Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World

Oct 28, 2024
pulisher
Oct 26, 2024

Comparing Mangoceuticals (MGRX) and Its Peers - Defense World

Oct 26, 2024
pulisher
Oct 26, 2024

Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa

Oct 26, 2024
pulisher
Oct 26, 2024

Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Reviewing Mangoceuticals (MGRX) & The Competition - Defense World

Oct 25, 2024
pulisher
Oct 24, 2024

Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World

Oct 24, 2024
pulisher
Oct 24, 2024

Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World

Oct 24, 2024
pulisher
Oct 23, 2024

Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World

Oct 23, 2024
pulisher
Oct 23, 2024

Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World

Oct 23, 2024
pulisher
Oct 23, 2024

Mangoceuticals (MGRX) versus Its Rivals Head to Head Review - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire

Oct 22, 2024
pulisher
Oct 21, 2024

Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx faces lawsuit from Eli Lilly over medication - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx faces lawsuit from Eli Lilly over medication By Investing.com - Investing.com UK

Oct 21, 2024
pulisher
Oct 21, 2024

Critical Contrast: Mangoceuticals (MGRX) and Its Rivals - Defense World

Oct 21, 2024
pulisher
Oct 21, 2024

Analyzing Mangoceuticals (MGRX) & Its Rivals - Defense World

Oct 21, 2024
pulisher
Oct 20, 2024

Reviewing Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Head-To-Head Contrast: Mangoceuticals (MGRX) vs. Its Peers - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Mangoceuticals (MGRX) and Its Competitors Head-To-Head Review - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Mangoceuticals (MGRX) and The Competition Critical Contrast - Defense World

Oct 19, 2024
pulisher
Oct 18, 2024

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 - Wetaskiwin Times Advertiser

Oct 18, 2024
pulisher
Oct 18, 2024

Mangoceuticals (MGRX) versus Its Competitors Financial Contrast - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Mangoceuticals, Inc. announced that it has received $0.15 million in funding - Marketscreener.com

Oct 17, 2024
pulisher
Oct 17, 2024

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga

Oct 17, 2024
pulisher
Oct 17, 2024

Contrasting Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Head-To-Head Comparison: Mangoceuticals (MGRX) & The Competition - Defense World

Oct 16, 2024
pulisher
Oct 15, 2024

Examining Mangoceuticals Inc (MGRX) more closely is necessary - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Mangoceuticals Inc (MGRX) Stock: A Year of Declines and Increases - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Upward Trajectory: Mangoceuticals Inc (MGRX) Posts a Slidee, Closing at 0.21 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Mangoceuticals Inc’s latest rating changes from various analysts - Knox Daily

Oct 14, 2024

Mangoceuticals Inc Azioni (MGRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$19.22
price up icon 1.21%
health_information_services EVH
$23.36
price down icon 0.43%
$16.81
price down icon 2.55%
health_information_services WAY
$28.65
price down icon 0.42%
health_information_services RCM
$14.28
price up icon 0.14%
health_information_services HQY
$86.95
price up icon 0.72%
Capitalizzazione:     |  Volume (24 ore):